JNJ vs JPM: Johnson & Johnson and JPMorgan Chase & compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- JPMorgan Chase & is the larger company, worth $878.7B, about 1.4 times Johnson & Johnson.
- JPMorgan Chase & grew revenue faster over the last year (+27.7% vs +6.6%).
- On earnings, JPMorgan Chase & is the cheaper stock (15.7x vs 30.5x).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | JNJ | JPM |
|---|---|---|
| Market cap | $632.9B | $878.7B |
| Share price | $261.44 | $332.99 |
| Revenue (last fiscal year) | $94.2B | $182.4B |
| Free cash flow (last fiscal year) | $19.7B | — |
| Revenue growth, last year | +6.6% | +27.7% |
| Revenue growth per year, last 5 fiscal years | +4.6% | +10.7% |
| Operating margin | — | — |
| Net margin | 21.5% | 32.6% |
| Return on equity | 24.8% | 17.4% |
| P/E (trailing) | 30.5x | 15.7x |
| Price / free cash flow | 32.1x | 8.72x |
| EV / EBITDA | 19.4x | 6.84x |
| FCF growth the price implies | 11.2% | — |
| Dividend yield | 2.0% | 1.8% |
| Debt / equity | 1.37x | 12.4x |
| Fundamental grade | C | B |
| Superinvestors holding it | 17 | 22 |
| Insider purchases, last 12 months | 10 | 10 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Johnson & Johnson
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $78.7B | $19.8B | — |
| 2022 | $80.0B | $17.2B | — |
| 2023 | $85.2B | $18.2B | — |
| 2024 | $88.8B | $19.8B | — |
| 2025 | $94.2B | $19.7B | — |
JPMorgan Chase &
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2021 | $121.6B | — | — |
| 2022 | $128.7B | — | — |
| 2023 | $158.1B | — | — |
| 2024 | $177.6B | — | — |
| 2025 | $182.4B | — | — |
Where the revenue comes from
Johnson & Johnson · by segments, 2025
Innovative Medicine$60.4B64%
MedTech$33.8B36%
JPMorgan Chase & · by segments, 2025
Commercial & Investment Bank$78.5B44%
Consumer & Community Banking$76.0B43%
Asset & Wealth Management$24.1B13%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open JNJ in InvestinglyQuestions
Which is bigger, Johnson & Johnson or JPMorgan Chase &?
JPMorgan Chase & (JPM), at $878.7B against $632.9B.
Is JNJ or JPM cheaper?
By trailing P/E, JPMorgan Chase & (15.7x) is cheaper than Johnson & Johnson (30.5x). A lower multiple can also mean the market expects less growth.
Which grows faster, JNJ or JPM?
JPMorgan Chase &: revenue grew +27.7% over the last year, against +6.6%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.